Moderna Co-chair on Pending FDA Review of Covid Vaccine
Click to rate this post!
[Total: 0 Average: 0]
You must sign in to vote
Dec.15 — Noubar Afeyan,co-chair at Moderna Inc., discusses a pending review by the U.S. FDA of the company’s vaccine to prevent Covid-19. Afeyan speaks on “Bloomberg Technology.”